Jennifer Tousignant's most recent trade in Viridian Therapeutics Inc was a trade of 124,072 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Viridian Therapeutics Inc | Jennifer Tousignant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 124,072 | 124,072 | - | - | Stock Option (Right to Buy) | |
Viridian Therapeutics Inc | Jennifer Tousignant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 20,679 | 20,679 | - | - | Restricted Stock Units | |
Viridian Therapeutics Inc | Jennifer Tousignant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 290,000 | 290,000 | - | - | Stock Option (Right to Buy) |